iBio, Inc. Files Updated Corporate Presentation (8-K)

What Happened
iBio, Inc. (IBIO) filed a Current Report on Form 8‑K on September 14, 2026, reporting under Item 7.01 and Item 8.01 that it has updated its corporate presentation. The presentation is attached as Exhibit 99.1 and includes "safe harbor" forward‑looking statements under the Private Securities Litigation Reform Act of 1995. The filing was signed by Marc A. Banjak, Chief Legal Officer.

Key Details

• Filing date: September 14, 2026; Form 8‑K covering Items 7.01 (Regulation FD disclosure) and 8.01 (Other events).
• Exhibit: Updated corporate presentation filed as Exhibit 99.1 (incorporated by reference).
• Content: Presentation includes standard "safe harbor" forward‑looking language; company notes it has no obligation to update the information but may do so.
• Use: Presentation is intended for meetings with investors, analysts and other audiences.

Why It Matters
This filing signals that iBio has refreshed the materials it uses to communicate strategy, pipeline and outlook to investors and analysts. Because the presentation contains forward‑looking statements, investors should treat predictive items as subject to risks and uncertainties disclosed elsewhere. The 8‑K does not report earnings, new financial results, or executive changes — it is a disclosure of updated investor communication materials under Regulation FD.